Press Release
Your NEXT Option™May / 2023
Video: Expanded Phase 1 Program to the Dallas Area

May / 2023
SA cancer research company entering Dallas market as it eyes more U.S., European expansion

Apr / 2023
NEXT Oncology Expands Phase I Program to Dallas Area

Jan / 2023
Grand Opening of joint venture brings access to proprietary Phase I program to more patients
Nov / 2022
Teon Therapeutics Announces First Patient Treated in Phase 1/2 Clinical Trial of TT-816, a Novel Oral Immune Checkpoint Inhibitor, in Patients with Advanced Solid Tumors

Oct / 2022
The Theresa Mays Endowed Merit Award Established for Promising Investigators Holding a PharmD Degree

Request Information From NEXT
We will respond to you with more information soon.Contact NEXT